Search for: "Pfizer Inc."
Results 1301 - 1320
of 1,379
Sorted by Relevance
|
Sort by Date
25 Apr 2015, 11:03 am
The first edition of the Reference Manual on Scientific Evidence [Manual] was published in 1994, a year after the Supreme Court delivered its opinion in Daubert. [read post]
20 May 2010, 12:46 pm
Pfizer, Inc., 490 F. [read post]
22 Feb 2008, 6:00 pm
Signature Financial Group, Inc., and AT&T Corp. v. [read post]
16 Aug 2009, 9:51 pm
In arguing their motion, Microsoft unfortunately relied on Schering Corp v Pfizer (1999) where, although the Court had excluded five surveys from evidence under the hearsay rule, the Court did not discuss Rule 703 save to say, damagingly for Microsoft, that it was an acceptable basis to admit survey evidence. [read post]
8 Jul 2012, 10:58 am
.); In re Pfizer Inc. [read post]
19 Apr 2013, 5:35 pm
Inc., 2012 U.S. [read post]
4 Apr 2008, 1:00 am
: (IPBiz) Pharma & Biotech - Products Abilify (Aripiprazole) – Otsuka files US patent infringement suit against Teva over seeking approval for generic Abilify: (IP Law360), Aricept (Donepezil) – US federal judge grants Eisai’s request for preliminary injunction blocking Teva from marketing generic version of Aricept: (IP Law360), (Orange Book Blog), Carbatrol (Carbamazepine) – US federal judge delivers mixed ruling in Shire… [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
15 Feb 2008, 9:00 am
: (Spicy IP),USD 20 billion going off-patent: (Patent Circle),Canadian Prices Review Board asserts jurisdiction over products sold in US, but imported into Canada under Special Access Program: (Gowlings),Canadian Court of Appeal affirms decision allowing patent-owner to be joined to proceedings: Cobalt v Pfizer and Pharmascience v Pfizer: (Gowlings),PharmaStem appeals stem cell patent: asks for greater deference to patent examiners:… [read post]
22 Jun 2010, 12:41 pm
Brief in opposition of respondents Independent Living Center of Southern California, Inc. et al. [read post]
6 Mar 2008, 6:00 am
Of course, whether reliance and causation are elements of a UCL claim is an unresolved question that the Supreme Court is expected to address in In re Tobacco and Pfizer. [read post]
18 Mar 2011, 10:04 am
Pfizer, 196 F. [read post]
18 Sep 2008, 8:56 pm
Conference of September 29, 2008 __________________ Docket: 07-811 Case name: Morris, et al. v Center for Bio-Ethical Reform, Inc. et al. [read post]
1 May 2008, 11:21 am
Beretta USA, Inc., No. 05-6942-cv (2d Cir. [read post]
7 Jan 2010, 10:36 am
Wyeth, Inc., 2007 WL 2458021 (E.D. [read post]
31 May 2007, 4:31 am
Pfizer, Inc., 2007 WL 1228784, at *3 (S.D. [read post]
14 May 2007, 7:03 am
Pfizer, Inc., 2006 WL 2819046, at *7-8 (D.N.J. [read post]
8 Dec 2016, 2:48 pm
These included—to give just one example—the drug manufacturers Wyeth and Pfizer Inc., which paid $784.6 million to resolve federal and state claims that Wyeth knowingly reported false prices on two acid reflux drugs. [read post]
3 May 2014, 8:56 am
Pfizer, Inc., 196 F. [read post]
9 Mar 2010, 12:20 am
In case after case, Tessera Inc. relied on Jianman Qu's expert testimony and computer model to prove patent infringement against the chip industry's biggest companies. [read post]
